Dr. Shashank K. is working as Senior Assistant Professor at the Department of Biochemistry, Central University of Punjab, Punjab, India. He worked as Post-Doctoral Fellow at the Department of Biochemistry, King George’s Medical University, India. Dr. Kumar did B.Sc. M.Sc. and Ph.D. Biochemistry from the Department of Biochemistry, University of Allahabad, India. Dr. Kumar has more than thirty published scientific papers/reviews/editorial articles in various National/International peer-reviewed Journals of repute. He has expertise in areas of Cancer Drug Discovery, Free radical biology, Cancer Biology, Cell culture techniques, Characterization of plant products, Xenobiotic metabolism, and Microbiology. He has presented his research findings in more than twenty-five National/International Conferences and attended about thirty Workshops at the majority of major Universities and Medical Colleges throughout India. Dr. Kumar is the Academic/Editorial Board Member and Reviewer of about twenty-five International Journal of repute. Dr. Kumar edited many books including, Concepts in Cell Signaling, Secondary Metabolites, and Functional Food Components, and Carbohydrate Metabolism Theory and Practical Approach, Phytochemistry: An in silico and in vitro updates, etc. Dr. Kumar is a lifetime member of Italo-Latin American Society of Ethnomedicine, Indian Sciences Congress Association, India, and a member of Publication Integrity & Ethics, London. His laboratory has been funded by University Grants Commission, India; Department of Science and Technology, SERB, India; and Indian Council of Medical Research India. Cancer aggressiveness, metastasis, drug resistance, cancer stem cell self-renewal/stemness, and disease relapse are some of the critical problems in the management of the disease. My laboratory is interested in targeting metabolic and molecular pathways in cancer and cancer stem cells by using preclinical cancer models and computer-aided drug discovery approach. We reported novel notch signaling inhibitor(s), and apoptosis inducer agents in cancer and cancer stem-like cells. For better management of the disease, we are trying to identify putative prognostic, diagnostic, and therapeutic biomarkers associated with cancer and cancer stemness at the gene and RNA (coding and non-coding) level. Recently we reported hub genes and miRNAs associated with the pathophysiology of cancer and cancer stemness/self-renewal property. My laboratory is also actively involved in the identification of medicinal properties of natural products against infectious and non-infectious diseases in collaboration with eminent scientists/research bodies across the world.